Diginex Shares Under Pressure Amid Aggressive Funding Strategy

Diginex is navigating a period of significant market turbulence. Investor sentiment has turned sharply negative, driven by concerns over how the company is financing its ambitious strategic pivot.

A Pivot Financed by Equity

The core of the issue lies in Diginex’s radical transformation from a crypto services provider to a sustainability software (ESG) specialist. To accelerate this shift, the company executed a double acquisition in early January, purchasing both AI specialist Plan A and “The Remedy Project.” It is the method of payment for these deals that has unsettled shareholders.

Rather than using cash reserves, Diginex is issuing new shares to fund the purchases. The acquisition of Plan A alone will require the issuance of 6.7 million new shares, with an additional one million shares being issued to pay for the second takeover. This approach results in a substantial dilution of existing shareholders’ equity, meaning each existing share represents a smaller ownership stake in the company.

Should investors sell immediately? Or is it worth buying Diginex?

Market Reaction and Chart Performance

The market’s disapproval of this financing strategy is evident in the share price performance. Key data points highlight the downward pressure:

• Significant Weekly Decline: Over the past seven trading days, Diginex equity has lost approximately 32% of its value.
• Broader Downtrend: The stock has been trading notably below its initial public offering price of $4.10 from January 2025.
• Minor Rebound Insufficient: A modest single-day recovery of 2.7% does little to alter the prevailing negative trend.

While management has placed a bold, forward-looking bet on its corporate transformation, current trading is dominated by dilution worries. The share price remains defensive, hovering near its lows, as the market awaits proof that the newly acquired subsidiaries can justify their significant cost to shareholders.